Boston’s top cancer center is diagnosing more patients with later-stage cancers, according to Laurie Glimcher, MD, Dana-Farber’s president and CEO.
“There was a decrease of about 90 percent of screening, whether it was pap smear, mammogram, colonoscopy,” she told Bloomberg. “We’re still not back up to the usual.”
Dr. Glimcher’s observations come nearly two months after a small study published in JAMA Network Open found late-stage breast and colorectal cancer diagnoses at University of California San Diego Health’s Moores Cancer Center jumped in 2020.
Dr. Glimcher said Dana-Farber physicians are working to find ways to diagnose cancer at earlier stages, when many can still be cured.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
